|
Volumn 57, Issue 2, 2003, Pages 46-51
|
The business case for medication safety.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
DRUG SURVEILLANCE PROGRAM;
ECONOMICS;
FINANCIAL MANAGEMENT;
HEALTH CARE COST;
HEALTH SERVICES RESEARCH;
HOSPITAL ORGANIZATION;
HUMAN;
IATROGENIC DISEASE;
INVESTMENT;
LEGAL LIABILITY;
MEDICAL INFORMATION SYSTEM;
MEDICATION ERROR;
SAFETY;
STANDARD;
UNITED STATES;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
CAPITAL EXPENDITURES;
CLINICAL PHARMACY INFORMATION SYSTEMS;
FINANCIAL MANAGEMENT, HOSPITAL;
HUMANS;
IATROGENIC DISEASE;
INVESTMENTS;
LIABILITY, LEGAL;
MEDICATION ERRORS;
MEDICATION SYSTEMS, HOSPITAL;
ORGANIZATIONAL CASE STUDIES;
SAFETY MANAGEMENT;
UNITED STATES;
|
EID: 0037315326
PISSN: 07350732
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|